Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2021 1
2022 1
2023 18
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
VAV3 in human cancers: Mechanism and clinical implication.
Al-Hawary SIS, Alsalamy A, Gupta R, Alsaab HO, Hjazi A, Edilboyev U, Ramadan MF, Hussien BM, Ahmed M, Hosseini-Fard SR. Al-Hawary SIS, et al. Among authors: hussien bm. Pathol Res Pract. 2023 Aug;248:154681. doi: 10.1016/j.prp.2023.154681. Epub 2023 Jul 13. Pathol Res Pract. 2023. PMID: 37467637 Review.
miR-221 and Parkinson's disease: A biomarker with therapeutic potential.
Zamanian MY, Ivraghi MS, Gupta R, Prasad KDV, Alsaab HO, Hussien BM, Ahmed H, Ramadan MF, Golmohammadi M, Nikbakht N, Oz T, Kujawska M. Zamanian MY, et al. Among authors: hussien bm. Eur J Neurosci. 2024 Jan;59(2):283-297. doi: 10.1111/ejn.16207. Epub 2023 Dec 3. Eur J Neurosci. 2024. PMID: 38043936 Review.
miR-495-3p as a promising tumor suppressor in human cancers.
Huldani H, Alshahrani SH, Almajidi YQ, Romero-Parra RM, Hjazi A, Alsaab HO, Oudaha KH, Hussien BM, Ahmed M, Fard SRH. Huldani H, et al. Among authors: hussien bm. Pathol Res Pract. 2023 Aug;248:154610. doi: 10.1016/j.prp.2023.154610. Epub 2023 Jun 8. Pathol Res Pract. 2023. PMID: 37307621 Review.
The cross-talk between LncRNAs and JAK-STAT signaling pathway in cancer.
Hjazi A, Obaid RF, Ali SS, Abdullaev B, Alsaab HO, Huldani H, Romero-Parra RM, Mustafa YF, Hussien BM, Saadoon SJ. Hjazi A, et al. Among authors: hussien bm. Pathol Res Pract. 2023 Aug;248:154657. doi: 10.1016/j.prp.2023.154657. Epub 2023 Jul 1. Pathol Res Pract. 2023. PMID: 37451194 Review.
Double-edged sword role of miRNA-633 and miRNA-181 in human cancers.
Gupta J, Suliman M, Ali R, Margiana R, Hjazi A, Alsaab HO, Qasim MT, Hussien BM, Ahmed M. Gupta J, et al. Among authors: hussien bm. Pathol Res Pract. 2023 Aug;248:154701. doi: 10.1016/j.prp.2023.154701. Epub 2023 Jul 20. Pathol Res Pract. 2023. PMID: 37542859 Review.
CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective.
Hjazi A, Ghaffar E, Asghar W, Alauldeen Khalaf H, Ikram Ullah M, Mireya Romero-Parra R, Hussien BM, Abdulally Abdulhussien Alazbjee A, Singh Bisht Y, Fakri Mustafa Y, Reza Hosseini-Fard S. Hjazi A, et al. Among authors: hussien bm. Biochem Pharmacol. 2023 Jul;213:115627. doi: 10.1016/j.bcp.2023.115627. Epub 2023 May 29. Biochem Pharmacol. 2023. PMID: 37257723 Review.
ETS transcription factor ELK3 in human cancers: An emerging therapeutic target.
Al-Hawary SIS, Pallathadka H, Hjazi A, Zhumanov ZE, Alazbjee AAA, Imad S, Alsalamy A, Hussien BM, Jaafer NS, Mahmoudi R. Al-Hawary SIS, et al. Among authors: hussien bm. Pathol Res Pract. 2023 Aug;248:154728. doi: 10.1016/j.prp.2023.154728. Epub 2023 Aug 1. Pathol Res Pract. 2023. PMID: 37542863 Review.
28 results